NovaBay Pharmaceuticals, Inc. And China Pioneer Pharma Announce Expansion Of Partnership Agreement

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

EMERYVILLE, Calif., and SHANGHAI, China, Dec. 2, 2013 (GLOBE NEWSWIRE) -- NovaBay Pharmaceuticals, Inc. (NYSE MKT:NBY), a clinical-stage biopharmaceutical company developing non-antibiotic antimicrobial products, today announced that it has expanded its NeutroPhase® commercial partnership agreement with China Pioneer Pharma Holdings Limited. (HK: 1345) ("Pioneer"), a Shanghai-based company that markets high-end pharmaceutical products. This agreement replaces the previous option to invest $3 million in NovaBay. The expanded agreement includes licensing rights to two new products, CelleRx™ and i-Lid™ Cleanser, developed by the MediBay Business Unit of NovaBay. The expanded partnership agreement covers the commercialization and distribution of these products in China and 11 countries in Southeast Asia.

Help employers find you! Check out all the jobs and post your resume.

Back to news